company? Let’s change
that.
Don't see your company?
Create a company profileIncisive Surgical, Inc. is a privately-held medical device company established to develop proprietary mechanical surgical solutions for
A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and infection prevention solutions and services. With annual sales of $12 billion and more than 44,000 associates, Ecolab delivers comprehensive solutions, data-driven insights and personalized service to advance food safety, maintain clean and safe environments, optimize water and energy use, and improve operational efficiencies and sustainability for customers in the food, healthcare, hospitality and industrial markets in more than 170 countries around the world. For more Ecolab news and information, visit www.ecolab.com, or follow us on twitter.com/ecolab, facebook.com/ecolab or instagram.com/ecolab_inc.
ACIST Medical Systems, Inc. is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange FFR and High Definition IVUS systems. It is also a global market leader in advanced contrast imaging systems for cardiovascular angiography and radiology imaging. Through these products, ACIST is demonstrating its commitment to bringing unique and innovative technologies that simplify cardiovascular procedures and empower clinicians to treat patients with superior care. As part of the Bracco Group, ACIST benefits from the resources of a multinational conglomerate with broad expertise in cath lab technology and a dedication to continuous advancement. Headquartered in Eden Prairie, Minnesota, USA, ACIST has worldwide presence with over 300 direct employees and facilities in Silicon Valley, Maastricht, Shanghai and Tokyo.
Emerging Therapy Solutions® (ETS) was founded in 2018 by industry veterans of managed care solutions, healthcare biotech and transplant to help healthcare payers manage the risks associated with high-cost therapies for rare and complex conditions. ETS acquired LifeTrac in 2020, bringing over 30 years of experience in bone marrow and solid organ transplants, plus provider relationships and agreements, to complement Emerging Therapy Solutions’ expertise in cell and gene therapies. The integrated business offers payers a comprehensive suite of services for solid organ and bone marrow transplants, cell and gene therapies, and other highly specialized therapies.
Medisyn Technologies is a unique bioactive compound design and discovery company for novel pharmaceuticals, nutraceuticals and animal health products. Through its proprietary Forward Engineering™ technology platform, Medisyn makes bioactive compound discovery faster, more predictable and less expensive. Based on molecular topology, Medisyn’s platform enables the discovery and design of novel, diverse and unexpected compounds in new chemical classes that meet exact parameters for a specific therapeutic use. By compressing design and discovery time from years to months and optimizing lead candidates, Medisyn’s novel approach enables customers to reduce risk, improve probability of success and control costs associated with the traditional lead discovery process.
CHF Solutions is a medical device company that focuses on innovative cardiac assist therapy to treat patients.
http://www.cardia.com
SILKTECH focuses on innovating and developing silk-derived protein (SDP) products for ophthalmic applications
Vergent Bioscience is a clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by significantly improving the visibility of tumors. Vergent’s lead compound, VGT-309, is a tumor-targeted fluorescent imaging agent intentionally designed to enable surgeons to see previously undetected or difficult-to-find tumors during surgery in real-time, ensuring all tumor tissue is removed. We are first evaluating VGT-309 in lung cancer, with the potential to expand its application to a wide range of solid tumors. Our approach directly addresses the clinical need and market opportunity for advanced visualization in open, laparoscopic, and robotic-assisted surgical procedures.
Enhanced Information Solutions provides Life Science manufacturers with mobile and computing technology to improve operations.
Immunochemistry Technologies is a strong business with an international distributor network.
Metavention develops medical devices to help with interventional therapies for Type 2 diabetes.
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
Adventium Labs is a research and development company
Vireo Health is a physician-led company dedicated to providing patients with best-in-class cannabis-based products and high quality care
NeuroOne is a medical technology company focused on improving surgical care for patients suffering from neurological disorders.
Cell Culture Company is a biotech organization located in Minneapolis, MN. Headquarters include corporate offices, manufacturing operations, regulated clean room spaces, and a distribution center. C3 offers tools and services to the therapeutic, cell therapy, diagnostic, genomic, animal health, food safety and research industries. C3 team members are experts in aseptic technique, bioreactor manufacturing, cell culture, purification, quality control, analytics and regulatory compliance. C3 has supported 20+ FDA clinical trials and serviced 1,700+ global laboratories. We are a growing biotech company with opportunities for talented individuals who want to support life-saving products.
General Probiotics develops innovative cellbots, antimicrobial probiotics that eliminate harmful pathogens in livestock.
Access Genetics and OralDNA Labs are in the business of personalized diagnostics
Life Epigenetics is an epigenetic testing company.
Work Your Passion. Live Your Purpose.